Fig. 6From: Identification of mitochondrial respiratory chain signature for predicting prognosis and immunotherapy response in stomach adenocarcinoma Identification of the clinical characteristics and predicting the STAD progression (A) Differences in clinicopathologic features of high-and low-MG score groups of STAD from the TCGA cohort. (B) Kaplan-Meier analysis of survival rate in patients with T1-2 between high-MG score group and low-MG score group in TCGA cohort. (C) Kaplan-Meier analysis of survival rate in patients with T3-4 between high-MG score group and low-MG score group in TCGA cohort. (D) Kaplan–Meier analysis of the prognosis between the high-MG score group and low-MG score group (log-rank tests, p-value < 0.001).Back to article page